Cargando…

Long-Term Stimulant Treatment Affects Brain Dopamine Transporter Level in Patients with Attention Deficit Hyperactive Disorder

OBJECTIVE: Brain dopamine dysfunction in attention deficit/hyperactivity disorder (ADHD) could explain why stimulant medications, which increase dopamine signaling, are therapeutically beneficial. However while the acute increases in dopamine induced by stimulant medications have been associated wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Gene-Jack, Volkow, Nora D., Wigal, Timothy, Kollins, Scott H., Newcorn, Jeffrey H., Telang, Frank, Logan, Jean, Jayne, Millard, Wong, Christopher T., Han, Hao, Fowler, Joanna S., Zhu, Wei, Swanson, James M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655054/ https://www.ncbi.nlm.nih.gov/pubmed/23696790 http://dx.doi.org/10.1371/journal.pone.0063023

Ejemplares similares

Motivation Deficit in ADHD is Associated with Dysfunction of the Dopamine Reward Pathway
por: Volkow, Nora D., et al.
Publicado: (2010)

Dopamine Transporters in Striatum Correlate with Deactivation in the Default Mode Network during Visuospatial Attention
por: Tomasi, Dardo, et al.
Publicado: (2009)

A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder
por: Wigal, Sharon B, et al.
Publicado: (2009)

Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day
por: Wigal, Sharon B, et al.
Publicado: (2010)

A Double-Blind, Placebo-Controlled, Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults with DSM-5 Attention-Deficit/Hyperactivity Disorder (ADHD)
por: Wigal, Tim L., et al.
Publicado: (2018)

Association between Dopamine D4 Receptor Polymorphism and Age Related Changes in Brain Glucose Metabolism
por: Volkow, Nora D., et al.
Publicado: (2013)

Methylphenidate Attenuates Limbic Brain Inhibition after Cocaine-Cues Exposure in Cocaine Abusers
por: Volkow, Nora D., et al.
Publicado: (2010)

Gender Effects in the Efficacy of Racemic Amphetamine Sulfate in Children with Attention-Deficit/Hyperactivity Disorder
por: Childress, Ann C., et al.
Publicado: (2019)

Review of Clinical Outcome Assessments in Pediatric Attention-Deficit/Hyperactivity Disorder
por: Markowitz, Jessica T, et al.
Publicado: (2020)

Association study of promoter polymorphisms at the dopamine transporter gene in Attention Deficit Hyperactivity Disorder
por: Xu, Xiaohui, et al.
Publicado: (2009)

Lisdexamfetamine Dimesylate for Preschool Children with Attention-Deficit/Hyperactivity Disorder
por: Childress, Ann C., et al.
Publicado: (2020)

Positive Emotionality is Associated with Baseline Metabolism in Orbitofrontal Cortex and in Regions of the Default Network
por: Volkow, Nora D., et al.
Publicado: (2011)

Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR) in Preschool Children with Attention-Deficit/Hyperactivity Disorder
por: Childress, Ann C., et al.
Publicado: (2020)

BMI Modulates Calorie-Dependent Dopamine Changes in Accumbens from Glucose Intake
por: Wang, Gene-Jack, et al.
Publicado: (2014)

Dopamine Appetite and Cognitive Impairment in Attention Deficit/Hyperactivity Disorder
por: Williams, Jonathan, et al.
Publicado: (2004)

Methylphenidate Decreased the Amount of Glucose Needed by the Brain to Perform a Cognitive Task
por: Volkow, Nora D., et al.
Publicado: (2008)

Genomic Features of the Human Dopamine Transporter Gene and Its Potential Epigenetic States: Implications for Phenotypic Diversity
por: Shumay, Elena, et al.
Publicado: (2010)

Emotional bias of cognitive control in adults with childhood attention-deficit/hyperactivity disorder
por: Schulz, Kurt P., et al.
Publicado: (2014)

Expectation effects on brain dopamine responses to methylphenidate in cocaine use disorder
por: Wang, Gene-Jack, et al.
Publicado: (2019)

Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies
por: Wigal, Sharon B, et al.
Publicado: (2020)

Post hoc analyses of response rates to pharmacological treatments in children and adolescents with attention-deficit/hyperactivity disorder
por: Coghill, David R, et al.
Publicado: (2020)

Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment
por: Huss, Michael, et al.
Publicado: (2016)

Decreased dopamine activity predicts relapse in methamphetamine abusers
por: Wang, GJ, et al.
Publicado: (2011)

Attenuated Tonic and Enhanced Phasic Release of Dopamine in Attention Deficit Hyperactivity Disorder
por: Badgaiyan, Rajendra D., et al.
Publicado: (2015)

A preliminary report of the dopamine receptor D(4) and the dopamine transporter 1 gene polymorphism and its association with attention deficit hyperactivity disorder
por: Niederhofer, Helmut, et al.
Publicado: (2008)

Efficacy and Safety of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder
por: Childress, Ann C., et al.
Publicado: (2018)

Reward‐enhancing effect of methylphenidate is abolished in dopamine transporter knockout mice: A model of attention‐deficit/hyperactivity disorder
por: Ide, Soichiro, et al.
Publicado: (2018)

Distribution and Pharmacokinetics of Methamphetamine in the Human Body: Clinical Implications
por: Volkow, Nora D., et al.
Publicado: (2010)

Association of Body Mass and Brain Activation during Gastric Distention: Implications for Obesity
por: Tomasi, Dardo, et al.
Publicado: (2009)

Connectivity supporting attention in children with attention deficit hyperactivity disorder
por: Barber, Anita D., et al.
Publicado: (2014)

Altered pattern of brain dopamine synthesis in male adolescents with attention deficit hyperactivity disorder
por: Forssberg, Hans, et al.
Publicado: (2006)

Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder
por: Wigal, Sharon B., et al.
Publicado: (2017)

Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder
por: Newcorn, Jeffrey H., et al.
Publicado: (2017)

Pre-Pregnancy Weight and Symptoms of Attention Deficit Hyperactivity Disorder and Executive Functioning Behaviors in Preschool Children
por: Fuemmeler, Bernard F., et al.
Publicado: (2019)

Population pharmacokinetics of methylphenidate hydrochloride extended-release multiple-layer beads in pediatric subjects with attention deficit hyperactivity disorder
por: Teuscher, Nathan S, et al.
Publicado: (2015)

PT546. The abolished rewarding effect of methylphenidate in dopamine transporter knockout mice, a model for attention deficit/hyperactivity disorder
por: Ide, Soichiro, et al.
Publicado: (2016)

A Pharmacokinetic Study of Methylphenidate Hydrochloride Multilayer Extended-Release Capsules (Aptensio XR(®)) in Preschool-Aged Children with Attention-Deficit/Hyperactivity Disorder
por: Adjei, Akwete L., et al.
Publicado: (2020)

Polygenic risk score analysis revealed shared genetic background in attention deficit hyperactivity disorder and narcolepsy
por: Takahashi, Nagahide, et al.
Publicado: (2020)

Association between Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms and obesity and hypertension in early adulthood: A population-based study
por: Fuemmeler, Bernard F., et al.
Publicado: (2010)

Dissociation in Neural Correlates of Hyperactive/Impulsive vs. Inattentive Symptoms in Attention-Deficit/Hyperactivity Disorder
por: Luo, Yu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0csvm2jm5foc61kfkodh39o8go